Vivos Therapeutics Inc
Research Vivos Therapeutics Inc (VVOS) on Bullrun: market cap USD 6.85M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerVVOS
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 6.85M
- Financial periodFY2025
- RevenueUSD 17.44M
- Revenue growth16.0%
- Net income-USD 21.17M
- Free cash flow-USD 17.60M
- Gross margin60.4%
Valuation Snapshot
latest market cap is USD 6.85M.
About Vivos Therapeutics Inc
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Frequently asked questions
What is Vivos Therapeutics Inc's market cap?
Vivos Therapeutics Inc's market capitalization is USD 6.85M.
What does Vivos Therapeutics Inc do?
Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.